Update on Novel Therapeutics for Primary CNS Lymphoma
Primary central nervous system lymphoma (PCNSL) is a rare lymphoma isolated to the central nervous system or vitreoretinal space. Standard treatment consists of cytotoxic methotrexate-based chemotherapy, with or without radiation. Despite high rates of response, relapse is common, highlighting the n...
Enregistré dans:
Auteurs principaux: | Lauren R. Schaff, Christian Grommes |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/af9b30bbf2c640b7ae8102c15224e36d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
par: Casey L. Anthony, et autres
Publié: (2021) -
Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions
par: Maliha Khan, et autres
Publié: (2021) -
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
par: Feng Z, et autres
Publié: (2021) -
THE TRANSFORMATION OF THE NOVEL IN THE CONTEXT OF KİRALIK KONAK, KÖR BAYKUŞ AND BİR KIŞ GECECİ EĞER BİR YOLCU
par: Fethi DEMİR, et autres
Publié: (2021) -
Novel treatments for osteoarthritis: a recent update
par: Wu Y, et autres
Publié: (2018)